About Dignify Therapeutics
Dignify Therapeutics is a private company based in Research Triangle Park, North Carolina. It has reported $4,245,868 raised in two offerings on Form D since October 2014. Its chief executive is Anthony DiTonno.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 25, 2026 | $800,000of $3.0M target | 2 | $400K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 10, 2014 | Oct 24, 2014amended Feb 25, 2015 | $3,445,868fully sold | 7 | $492K | EquityRule 506(c) | Form D/A ↗1 earlier filing |
| Total, two offerings | $4,245,868 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Dignify Therapeutics's Form D filed Sep 25, 2026.
Earlier filings also listed Venkateswarlu Karicheti (promoter, last listed Feb 2015), Tatyana Touzova (promoter, last listed Feb 2015), Mary Katofiasc (promoter, last listed Feb 2015), Lesley Marson (promoter, last listed Feb 2015), Fred Eshelman (director, last listed Feb 2015), Florenta Kullmann (promoter, last listed Feb 2015), Ebrahim Versi (director and promoter, last listed Feb 2015) and Daniel Ricca (director and promoter, last listed Feb 2015).